Skip to main content
. 2020 Mar 11;12(3):655. doi: 10.3390/cancers12030655

Figure 9.

Figure 9

The scheme for molecular mechanisms of BNIP3L-dependent mitophagy-mediated reprogramming of glycolytic metabolism promoted cancer stemness in HBx-expressing HCC cells. In vivo, HBx-expressing promoted xenografted tumor growth, upregulated the expression of liver cancer stemness and BNIP3L-dependent mitophagy-related proteins, and increased the glycolytic metabolism. In vitro, HBx upregulated glycolysis metabolism reprogramming through BNIP3L-dependent mitophagy, and consequently enhanced the hepatic cancer stemness phenotypes in multiple HBx-expressing HCC cell models.